Modifiable factors associated with copeptin concentration: a general population cohort

Area of Science:

• Nephrology
• Endocrinology
• Public Health

Background:

• Vasopressin is crucial for fluid balance but may worsen chronic kidney disease (CKD).
• Identifying modifiable factors influencing vasopressin is essential for CKD management.
• Copeptin serves as a reliable biomarker for vasopressin levels.

Purpose of the Study:

• To identify lifestyle and dietary factors associated with vasopressin concentration, using copeptin as a surrogate.
• To explore potential targets for intervention to reduce vasopressin levels and mitigate renal damage.

Main Methods:

• Cross-sectional analysis of 6,801 participants from the PREVEND cohort study.
• Copeptin levels measured via immunoluminometric assay.
• Associations with lifestyle and diet factors assessed using multivariable linear regression.

Main Results:

• Higher copeptin concentrations were linked to lower 24-hour urine volume, higher sodium excretion, elevated blood pressure, current smoking, increased alcohol consumption, higher BMI, and higher plasma glucose.
• Associations were also found with higher urea and lower potassium excretion.
• No significant associations were observed with C-reactive protein or diuretic/antihypertensive use.

Conclusions:

• Current smoking, alcohol use, protein and potassium intake, and particularly fluid and sodium intake are significantly associated with vasopressin levels.
• These findings support further investigation into lifestyle interventions for managing vasopressin and potentially improving renal outcomes.
• The study's cross-sectional design limits definitive causal conclusions.